Article by Guardian President Published in Clinical Cancer Research

Article details outcomes of colorectal cancer

Timothy J. Yeatman, MD, Director and President of Gibbs Cancer Center & Research Institute, recently had an article published in Clinical Cancer Research, a “high impact” journal of the American Association for Cancer Research. The publication describes a new molecular signature that predicts colorectal cancer metastasis and progression and could help physicians make decisions on therapies for patients.  His research was funded by the National Cancer Institute and was performed in the Gibbs Cancer Center Research Laboratory.

Read the study by clicking here.

The Gibbs Cancer Center & Research Institute is dedicated to cure and eradicate cancer.  Gibbs has invested in basic, translational and clinical research to find new ways to achieve these goals. Passionate about personal cancer care, Dr. Yeatman works to bring clinical cancer trials to community cancer centers so patients and their families don’t have to travel far distances for care.

Dr. Yeatman’s research explores a composite gene expression signature and how it optimizes predictions of colorectal cancer metastasis and outcomes. Dr. Yeatman was one of 10 researchers who contributed to the study.

Dr. Yeatman’s surgical oncology career spans more than 20 years and he specializes in treating gastrointestinal cancer. He has published more than 200 articles in top peer-reviewed medical journals that have led to numerous patents and licenses.

About Gibbs Cancer Center & Research Institute

Gibbs Cancer Center & Research Institute is a nationally recognized cancer treatment and research facility associated with the National Cancer Institute Community Cancer Center program and the Medical University of South Carolina. Named for benefactors Marsha and Jimmy Gibbs and with locations in Spartanburg, Gaffney and Greer, Gibbs is a proven leader in providing effective cancer treatment through advanced technology, professional expertise and an exceptional level of personalized care. Gibbs’ oncology program, which also includes the Bearden-Josey Center for Breast Health, has been recognized by the Commission on Cancer of the American College of Surgeons as offering high-quality cancer care. In 2012, Gibbs joined forces with Bon Secours St. Francis Health System to expand world-class oncology services and clinical research in the Upstate. In 2013, the Gibbs expanded its research efforts by opening a 7,500-square-foot state-of-the-art facility at Pelham Medical Center.